215 related articles for article (PubMed ID: 10986181)
21. Maternal serum triple analyte screening in pregnancy.
Graves JC; Miller KE; Sellers AD
Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
[TBL] [Abstract][Full Text] [Related]
23. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Hogge WA; Fraer L; Melegari T
Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
[TBL] [Abstract][Full Text] [Related]
24. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270
[TBL] [Abstract][Full Text] [Related]
25. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
26. [Maternal serum screening for Down syndrome and neural tube defects].
van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
[TBL] [Abstract][Full Text] [Related]
27. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
van den Boer-van den Berg JM; Dupuis HM
Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
[No Abstract] [Full Text] [Related]
28. The effects of analytical factors on second trimester risk estimations.
Serdar MA; Tütüncü L; Olgun A; Haşimi A; Ozgurtaş T; Erbil MK
Int J Gynaecol Obstet; 2006 Apr; 93(1):28-32. PubMed ID: 16530198
[TBL] [Abstract][Full Text] [Related]
29. A 35-year-old pregnant woman considering maternal serum screening and amniocentesis.
Mennuti M
JAMA; 1996 May; 275(18):1440-6. PubMed ID: 8618372
[No Abstract] [Full Text] [Related]
30. Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes.
Chitayat D; Farrell SA; Huang T; Meier C; Wyatt PR; Summers AM
Am J Obstet Gynecol; 2002 Sep; 187(3):758-63. PubMed ID: 12237660
[TBL] [Abstract][Full Text] [Related]
31. Maternal serum screening for neural tube defects and Down syndrome.
Keith D
Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
[No Abstract] [Full Text] [Related]
32. Maternal serum screening.
Carroll JC
Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
Summers AM; Huang T; Wyatt PR
Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
[No Abstract] [Full Text] [Related]
34. [Localization of gestational age reference table and its application in prenatal screening].
Dou L; Yang G; Mo W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 46(1):59-65. PubMed ID: 28436632
[TBL] [Abstract][Full Text] [Related]
35. Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
Macri JN; Anderson RW; Krantz DA; Larsen JW; Buchanan PD
Am J Obstet Gynecol; 1996 Feb; 174(2):566-72. PubMed ID: 8623786
[TBL] [Abstract][Full Text] [Related]
36. Maternal serum screening for birth defects: results of a Connecticut regional program.
Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
[TBL] [Abstract][Full Text] [Related]
37. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
Rose NC; Mennuti MT
West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
[TBL] [Abstract][Full Text] [Related]
38. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
[TBL] [Abstract][Full Text] [Related]
39. Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.
Ying I; Wyatt PR; Nisenbaum R; Ray JG
J Obstet Gynaecol Can; 2011 Dec; 33(12):1218-1222. PubMed ID: 22166275
[TBL] [Abstract][Full Text] [Related]
40. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
Craig WY; Haddow JE; Palomaki GE; Roberson M
Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
